SCHEMBL26324209

SCHEMBL26324209

Cc1ccc(C(=O)Nc2cccc(Oc3ccncc3)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
CYP3A4 P08684 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
KCNK3 O14649 2/20 0.59
KCNK9 Q9NPC2 1/20 0.59
RAF1 P04049 1/20 0.57
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
HPSE Q9Y251 1/20 0.56
TP53 P04637 3/20 0.56
NAMPT P43490 3/20 0.56
PKM P14618 1/20 0.56
KMT2A Q03164 1/20 0.56
NR1H4 Q96RI1 1/20 0.55
KDM1A O60341 1/20 0.54
RCOR1 Q9UKL0 1/20 0.54
RECQL P46063 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13211973 0.89 NR1H4 (0.68) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL30396799 0.88 KCNK3 (0.71) KCNK3KCNK9RAF1NPC1RAB9A
SCHEMBL26324119 0.87 RAF1 (0.57) ALDH1A1KCNK3RAF1NPC1RAB9A
SCHEMBL24003740 0.87 RAF1 (0.57) ALDH1A1KCNK3RAF1NPC1RAB9A
SCHEMBL24004043 0.87 HPSE (0.56) ALDH1A1KCNK3RAF1NPC1RAB9A
SCHEMBL13192838 0.86 KMT2A (0.64) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL14684329 0.85 NR1H4 (0.71) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL13192835 0.85 KCNK3 (0.62) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL24003736 0.83 RAF1 (0.51) ALDH1A1KCNK3KCNK9RAF1NPC1
SCHEMBL24003968 0.83 NPC1 (0.51) ALDH1A1KCNK3KCNK9RAF1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR ALDH1A1 4544/4885CYP3A4 3903/4885CYP1A2 3880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.